Ramipril Treatment of Claudication: Oxidative Damage and Muscle Fibrosis — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Ramipril Treatment of Claudication: Oxidative Damage and Muscle Fibrosis — Stella

Home/Peripheral Arterial Disease/

View on ClinicalTrials.gov

Recruiting

Back to Peripheral Arterial Disease trials

Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.

Trial locations(1 site)

United States

VA Medical Center, Omaha, Nebraska

Key details

Phase

Post-approval study

Sponsor

University of Nebraska

Enrollment target

~70 participants

Started

February 2016

Primary completion

June 2026

Age range

18 Years – 90 Years

Last updated May 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.